Back to search

Article

Safety, tolerability and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD) trial

2024-05-16

Abstract excerpt

<h4>Objective</h4> To assess whether the antiseizure medication levetiracetam may improve cognition in individuals with Alzheimer’s disease who have not previously experienced a seizure. <h4>Methods</h4> We performed a randomised, double-blind, placebo-controlled crossover study in individuals with mild-to-moderate Alzheimer’s disease. Electroencephalography was performed at baseline and those with active epilepti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
907fcabb-781a-5b36-b098-3bebb9055d39
DOI
10.1101/2024.05.14.24307228
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety, tolerability and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD) trialDOI 10.1101/2024.05.14.24307228
APOE-specific Cognitive Effects of Levetiracetam in Mid-Age AdultsSemantic proximity
Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies.Semantic proximity
Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial.Semantic proximity
Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.Semantic proximity
Levetiracetam Alleviates Cognitive Decline in Alzheimer’s Disease Animal Model by Ameliorating the Dysfunction of the Neuronal NetworkSemantic proximity
Istradefylline Safety Profiles: Examination of Individual Case Safety Reports in the FDA Adverse Event Reporting System (FAERS) DatabaseSemantic proximity
Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.Semantic proximity
The effects of rasagiline on cerebral glucose metabolism, cognition, and tau in a double-blind, placebo-controlled Phase II clinical trial in Alzheimer’s dementiaSemantic proximity
Geographic variation in dementia-related adverse events associated with sacubitril/valsartan: Analysis of the FDA Adverse Event Reporting SystemSemantic proximity
Utility of the ADAS-Cog as a Cognitive Screening Tool in Older Adults with Epilepsy: A Multicenter Cohort StudySemantic proximity
Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.Semantic proximity
Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?Semantic proximity
Select a neighboring publication to make it the new centre.